Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06073301 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AFS Compared to AHC in Treatment of Necrotizing Fasciitis NF

Study acronym: NF
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 30, 2024 (before its estimated August 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  2. Re-verified, no change to tracked fieldsv3
  3. Interventions: Acellular Fish Skin Graft (AFS) and Negative Pressure Wound Therapy (NPWT) (Device), Acellular Human Cadaver (AHC) and Negative Pressure… to Acellular Fish Skin Graft (AFS) with Standard of Care Negative Pressure Wound Therapy (NPWT) (Device), Acellular Human Cadaver (AHC) with…v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Necrotizing Fasciitis (NF) is a potentially life-threatening soft tissue infection. This study is comparing acellular fish skin graft (AFS) to standard of care allograft (AHC) in the treatment of NF. The purpose of this study is to compare clinical outcomes and time until autograft take in patients that were treated with AHC or AFS prior to permanent autografting to treat NF.
Trial Details
NCT Number NCT06073301
Lead Sponsor Kerecis Ltd.
Collaborators: Joseph M. Still Research Foundation, Inc.
Conditions
(from sponsor)		 Necrotizing Fasciitis
Related terms Fasciitis, Necrotizing
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov